PRESS-NEWS.org - Press Release Distribution
PRESS RELEASES DISTRIBUTION

Immunotherapy could stop resistance to radiotherapy

2014-10-01
(Press-News.org) Treating cancers with immunotherapy and radiotherapy at the same time could stop them from becoming resistant to treatment, according to a study published in Cancer Research* today (Wednesday).

The researchers, based at The University of Manchester and funded by MedImmune, the global biologics research and development arm of AstraZeneca, and Cancer Research UK, found that combining the two treatments helped the immune system hunt down and destroy cancer cells that weren't killed by the initial radiotherapy in mice with breast, skin and bowel cancers.

Radiotherapy is a very successful treatment for many forms of cancer, but in cancer cells that it doesn't kill it can switch on a 'flag' on their surface, called PD-L1, that tricks the body's defences into thinking that cancerous cells pose no threat.

The immunotherapy works by blocking these 'flags' to reveal the true identity of cancer cells, allowing the immune system to see them for what they are and destroy them.

The approach improved survival and protected the mice against the disease from returning.

Dr Simon Dovedi, the lead researcher based at The University of Manchester and member of the Manchester Cancer Research Centre, said: "Using the body's own defences to treat cancers has huge potential with early phase clinical trials demonstrating exciting patient benefit but we are still at the early stages of understanding how best to use these types of treatments. Combining certain immunotherapies with radiotherapy could make them even more effective and we're now looking to test this in clinical trial to see just how much of a difference it could make."

Professor Nic Jones, Cancer Research UK's chief clinician, said: "Around half of all cancer patients are given radiotherapy and it has been at the heart of helping improve survival rates so that today one in two cancer patients will survive for at least ten years. Doctors and researchers are constantly looking for ways to improve treatments and this approach could open the door to a whole new way of giving radiotherapy."

Dr Robert Wilkinson, Director of Oncology Research, MedImmune, said: "MedImmune is committed to developing strong science led collaborations, and supporting research that helps further advance our scientific understanding in the important area of immunotherapy. The findings described in the recent study with Cancer Research UK are extremely encouraging."

Cancer Research UK joined forces with The Christie NHS Foundation Trust and The University of Manchester to form the Manchester Cancer Research Centre allowing doctors and scientists to work closely together to turn scientific advances into patient benefits sooner.

INFORMATION:

Notes to editors:

*Dovedi, S.J., et al. Acquired resistance to fractionated radiation therapy can be overcome by concurrent PD-L1 blockade (2014) Cancer Research


ELSE PRESS RELEASES FROM THIS DATE:

Is Australia prepared for Ebola?

2014-10-01
Australia needs to be proactive about potential disease outbreaks like Ebola and establish a national centre for disease control. In an Editorial in the October issue of Australian and New Zealand Journal of Public Health, Allen Cheng from Monash University and Heath Kelly from the Australian National University question Australia's preparation for public health crises. "Australia would do well to heed the lessons learned in other countries and be proactive in co-ordinating a consistent and outward looking response," the authors said. "Australia needs a national disease ...

Targeted treatment could halt womb cancer growth

2014-10-01
A drug which targets a key gene fault could halt an aggressive womb cancer and shrink tumours, according to research published in the British Journal of Cancer*. The scientists, from the Division of Gynaecologic Oncology at Yale School of Medicine funded by the National Institutes of Health, showed that the drug afatinib not only killed off uterine serous cancer cells after stopping their growth but also caused tumours to shrink. The drug, a type of personalised medicine, attacks faults in the HER2 gene which lie at the heart of the cancer cells. This stops the disease ...

Third of countries struggling to meet the needs of aging population

2014-10-01
People around the world are living longer, but social policies to support their wellbeing in later life are lagging behind in many countries. This is according a new report by HelpAge International, developed in partnership with the University of Southampton. More than a third of countries are falling significantly behind those at the top of the Global AgeWatch Index. It ranks 96 nations on the basis of the quality of life and social and economic wellbeing of older people (over 60s). The Index can also help governments to identify policies and institutional contexts that ...

Developing countries should enroll medical and nursing students from rural areas

2014-10-01
Nearly one third of medical and nursing students in developing countries may have no intention of working in their own countries after graduation, while less than one fifth of them intend to work in rural areas where they are needed most, according to a new study. Health workforce shortages have been a major factor driving the current outbreak of Ebola in western Africa. The disease initially spread rapidly in rural parts of three of the world's poorest countries (Guinea, Sierra Leone and Liberia), where health workers are scarcest. The study, which was published in ...

Minimum alcohol pricing would be up to 50 times more effective than below cost selling ban

2014-10-01
The previous policy of setting a minimum unit price would have had a 40-50 times greater effect, particularly among harmful drinkers, say researchers. Increasing the price of alcohol has been shown to be effective in reducing both consumption levels and harms, and the UK government has been considering different policy options for price regulation in England and Wales. In 2010, the government announced a ban on "below cost selling" to target drinks which are currently sold so cheaply that their price is below the cost of the tax (duty and VAT) payable on the product. ...

Healthy lifestyle could prevent nearly half of all diabetic pregnancies

2014-10-01
Gestational diabetes is a common pregnancy complication that has long-term adverse health implications for both mothers and babies. Several modifiable risk factors before pregnancy have been identified over the past decade. These include maintaining a healthy weight, consuming a healthy diet, regular physical activity, and not smoking. So a team of researchers based in the United States set out to examine the effect of these "low risk" lifestyle factors on the risk of gestational diabetes – and measure the portion of the condition that may be preventable through adhering ...

The Lancet: Latest estimates show that preterm birth complications and pneumonia are the leading causes of death in children under 5 years

2014-10-01
Complications from preterm (premature) births and pneumonia are now the leading causes of death in children under five years, together responsible for nearly 2 million deaths in 2013, according to the latest estimates, published today [Tuesday 30 September] in The Lancet. Researchers led by Professor Robert Black, of Johns Hopkins Bloomberg School of Public Health, Baltimore, USA, used the latest available data and modelling methods to examine what caused an estimated 6•3 million deaths of newborn babies (neonates) and children under five years in 2013. They found that ...

The Lancet Diabetes & Endocrinology: Genetic study casts further doubt that vitamin D prevents the development of type 2 diabetes

2014-10-01
A large genetic study, published today in The Lancet Diabetes & Endocrinology journal, has concluded there is no evidence of a causal link between a person's vitamin D levels [1], and whether they develop type 2 diabetes. The findings of the study, conducted by scientists at the University of Cambridge, challenge evidence from earlier observational studies which suggest that higher concentrations of circulating vitamin D might prevent type 2 diabetes. This evidence led to speculation that the development of type 2 diabetes is associated with vitamin D insufficiency. ...

Improving babies' language skills before they're even old enough to speak

Improving babies language skills before theyre even old enough to speak
2014-10-01
In the first months of life, when babies begin to distinguish sounds that make up language from all the other sounds in the world, they can be trained to more effectively recognize which sounds "might" be language, accelerating the development of the brain maps which are critical to language acquisition and processing, according to new Rutgers research. The study by April Benasich and colleagues of Rutgers University-Newark is published in the October 1 issue of the Journal of Neuroscience. The researchers found that when 4-month-old babies learned to pay attention to ...

New genetic 'operating system' facilitated evolution of 'bilateral' animals

2014-10-01
The evolution of worms, insects, vertebrates and other "bilateral" animals—those with distinct left and right sides—from less complex creatures like jellyfish and sea anemones with "radial" symmetry may have been facilitated by the emergence of a completely new "operating system" for controlling genetic instructions in the cell. That's the hypothesis of molecular biologists at UC San Diego. They report in the October 1 issue of the journal Genes & Development that this new system of controlling gene networks, analogous to a new computer operating system, paved the way ...

LAST 30 PRESS RELEASES:

Hyperspectral sensor pushes weed science a wave further

War, trade and agriculture spread rice disease across Africa

Study identifies a potential treatment for obesity-linked breathing disorder

From single cells to complex creatures: New study points to origins of animal multicellularity

Language disparities in continuous glucose monitoring for type 2 diabetes

New hormonal pathway links oxytocin to insulin secretion in the pancreas

Optimal management of erosive esophagitis: An evidence-based and pragmatic approach

For patients with multiple cancers, a colorectal cancer diagnosis could be lifesaving — or life-threatening

Digital inhalers may detect early warning signs of COPD flare-ups

Living near harmful algal blooms reduces life expectancy with ALS

Chemical analysis of polyphenolic content and antioxidant screening of 17 African propolis samples using RP-HPLC and spectroscopy

Mount Sinai and Cancer Research Institute team up to improve patient outcomes in immunotherapy

Suicide risk elevated among young adults with disabilities

Safeguarding Mendelian randomization: editorial urges rethink in methodological rigor

Using AI to find persuasive public health messages and automate real-time campaigns

Gene therapy for glaucoma

Teaching robots to build without blueprints

Negative perception of scientists working on AI

How disrupted daily rhythms can affect adolescent brain development

New use for old drug: study finds potential of heart drug for treating growth disorders

Head-to-head study shows bariatric surgery superior to GLP-1 drugs for weight loss

Psychiatric disorders less likely after weight-loss surgery than treatment with GLP-1s

The higher the body mass index, the higher the risk for complications after bariatric surgery

Black patients have higher rate of minor complications after metabolic and bariatric surgery than white patients

A revolution for R&D with the missing link of machine learning — project envisions human-AI expert teams to solve grand challenges

4 ERC Advanced Grants: 10 million Euro for ISTA

ERC awards €2.5 million to TIGEM scientist for project on programmable genetic circuits

Tree rings reveal increasing rainfall seasonality in the Amazon

Scientists find unexpected deep roots in plants

Researchers unveil the immune cells responsible for systemic sclerosis’s deadliest complications

[Press-News.org] Immunotherapy could stop resistance to radiotherapy